Systemic listeriosis with adalimumab therapy.
Murphy
Grainne
G
Department of Rheumatology, Cork University Hospital, Wilton, Cork, Ireland. grainne.murphy@ucc.ie
Schmidt-Martin
Daniel
D
Hynes
Brian Gerard
BG
Harney
Sinead
S
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D015994:Incidence; D008089:Listeria monocytogenes; D008088:Listeriosis / Q000453:epidemiology*; D008875:Middle Aged; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab